Amol Dongre
Associate Professor Dept. of Medical Oncology Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences Sawangi (Meghe) Wardha
Shriram Kane
Professor Dept. of Medical Oncology Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences Sawangi (Meghe) Wardha
Abstract
BACKGROUND: Ovarian cancer is the sixth most frequent cancer in women and the second most prevalent gynaecological malignancy. It has the greatest mortality rate of any gynaecological cancer, with a 5-year survival rate of 46%. The severe disease at the time of diagnosis is a major contributor to the high death rate, making it critical to identify these lesions early in their progression.
AIM AND OBJECTIVE: The goal of this study is to see how patients with ovarian tumours are treated at a tertiary health care facility.
METHODOLOGY: This trial lasted two years and included 120 individuals with ovarian cancer. A pre-tested questionnaire was used to collect data. Sociodemographic information, clinical history, and a clinical assessment were all included in the study. The treatment was tailored to the specific form of ovarian tumour. The effects of an ovarian tumour have been observed. Data was analysed using statistical tests.
RESULTS: Ovarian cancer was found to be 5.9% of the time. In the study, 65 percent of the tumours were benign, whereas 35 percent were malignant. Cystectomy was the most common treatment for ovarian tumours (44.8 percent ).
CONCLUSION: Cystectomy was the most prevalent treatment for ovarian tumours (44.82 percent), followed by total abdominal hysterectomy and bilateral salphingo oopherectomy (29.31 percent).
KEYWORDS: ovarian tumours, gynaecological malignancy, adnexal mass.